arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Gevo, Inc.

GEVO
$1.46 ▼ -0.10 (-6.43%) at close
Materials ·Industrial Organic Chemicals ·USIndustrial Organic Chemicals
21 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
37
Health
Weak
Bearish
auto_awesome

Analytical Summary

Gevo, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $341.7M
Dividend Yield —
Revenue Growth 849.3% ↗
Op. Margin -12.6%
ROIC -2.5% ↗
FCF / Share $-0.19 ↗
Trailing P/E —
Price / Book 0.8x
FCF Yield —
Debt / Equity 0.35
info Valuation on last close. End-of-day price, Sep 23, 2026.

21-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$160.58M
↑ +849.3% —
Net Income Profit after all expenses
$-33.84M
↑ +57.0% —
Operating Margin Operating profit as % of sales
-12.6%
↑ +97.4% 13th
FCF / Share Free cash flow per share
$-0.19
↑ +60.3% —
Long-Term Debt Long-term obligations
$164.75M
↑ +145.4% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
10
Returns ↑
36
Financial Health ↑
52
Cash Quality ↓
75

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 21 years · 71 quarters